# reload+after+2024-01-21 02:47:56.015612
address1§7921 Southpark Plaza
address2§Suite 210
city§Littleton
state§CO
zip§80120
country§United States
phone§866 908 4867
website§https://vivos.com
industry§Medical Devices
sector§Healthcare
longBusinessSummary§Vivos Therapeutics, Inc., a medical technology company, develops and commercializes treatment alternatives for patients with dentofacial abnormalities, obstructive sleep apnea (OSA), and snoring in adults. It offers The Vivos Method, a non-invasive, non-surgical, non-pharmaceutical, multi-disciplinary treatment modality for the treatment of dentofacial abnormalities, OSA, and snoring. The company also offers VivoScore Program, a screening and home sleep test in adults and children. It markets and sells its appliances, and related treatments and services to licensed professionals, primarily general dentists in the United States and Canada. The company was founded in 2016 and is based in Littleton, Colorado.
fullTimeEmployees§154
companyOfficers§[{'maxAge': 1, 'name': 'Mr. R. Kirk Huntsman', 'age': 65, 'title': 'Co-Founder, Chairman of the Board & CEO', 'yearBorn': 1958, 'fiscalYear': 2022, 'totalPay': 454048, 'exercisedValue': 0, 'unexercisedValue': 0}, {'maxAge': 1, 'name': 'Mr. Bradford K. Amman', 'age': 61, 'title': 'CFO, Treasurer & Secretary', 'yearBorn': 1962, 'fiscalYear': 2022, 'totalPay': 297228, 'exercisedValue': 0, 'unexercisedValue': 0}, {'maxAge': 1, 'name': 'Mr. Todd  Huntsman', 'title': 'Co-Founder & Senior VP of Product and Technology', 'fiscalYear': 2022, 'exercisedValue': 0, 'unexercisedValue': 0}, {'maxAge': 1, 'name': 'Ms. RaeAnn  Byrnes', 'title': 'Co-Founder and Senior VP of Events & Clinical Advisory Services', 'fiscalYear': 2022, 'exercisedValue': 0, 'unexercisedValue': 0}, {'maxAge': 1, 'name': 'Ms. Susan  McCullough', 'title': 'Co-Founder, Executive VP & Chief Experience Officer', 'fiscalYear': 2022, 'exercisedValue': 0, 'unexercisedValue': 0}, {'maxAge': 1, 'name': 'Ms. Julie  Gannon', 'title': 'Senior VP of Product, Sales & Marketing and Investor Relations Officer', 'fiscalYear': 2022, 'exercisedValue': 0, 'unexercisedValue': 0}, {'maxAge': 1, 'name': 'Mr. Nicholas M. DeGennaro', 'title': 'Senior Vice President of Medical Division', 'fiscalYear': 2022, 'exercisedValue': 0, 'unexercisedValue': 0}, {'maxAge': 1, 'name': 'Ms. Ruth  Hembree', 'title': 'Senior Vice President of Practice Services', 'fiscalYear': 2022, 'exercisedValue': 0, 'unexercisedValue': 0}, {'maxAge': 1, 'name': 'Ms. Stephanie  Huebner', 'title': 'Senior Vice President of DSO Operations', 'fiscalYear': 2022, 'exercisedValue': 0, 'unexercisedValue': 0}]
compensationAsOfEpochDate§1672444800
maxAge§86400
priceHint§2
payoutRatio§0.0
beta§8.376
priceToSalesTrailing12Months§0.8568829
currency§USD
dateShortInterest§1702598400
forwardEps§-4.62
exchange§NCM
quoteType§EQUITY
shortName§Vivos Therapeutics, Inc.
longName§Vivos Therapeutics, Inc.
firstTradeDateEpochUtc§1607697000
timeZoneFullName§America/New_York
timeZoneShortName§EST
uuid§f7841f7b-8a17-3bee-8208-204a6caf321b
gmtOffSetMilliseconds§-18000000
targetHighPrice§6.0
targetLowPrice§6.0
targetMeanPrice§6.0
targetMedianPrice§6.0
recommendationMean§2.0
recommendationKey§buy
numberOfAnalystOpinions§1
quickRatio§0.17
grossMargins§0.59064
ebitdaMargins§-1.2814599
trailingPegRatio§None
